Trials / Unknown
UnknownNCT05401422
Brimonidine in Rosacea
Efficacy and Safety of Combining Doxycycline With Pulsed Dye Laser Versus Topical Brimonidine 0.33% in the Treatment of Erythematotelangiectatic Rosacea: a Comparative Clinical and Dermoscopic Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Rosacea is a chronic and relapsing inflammatory cutaneous disorder with highly variable prevalence worldwide.
Detailed description
In our study, we will compare the safety, efficacy, and adverse effects of low-dose oral doxycycline alone versus combined with pulsed dye laser or topical brimonidine in treating erythematotelangiectatic rosacea in an attempt to build a treatment strategy in a disease with complex pathogenesis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | treatment | types |
Timeline
- Start date
- 2022-05-25
- Primary completion
- 2022-09-15
- Completion
- 2022-09-15
- First posted
- 2022-06-02
- Last updated
- 2022-06-02
Source: ClinicalTrials.gov record NCT05401422. Inclusion in this directory is not an endorsement.